表紙
市場調査レポート

オリゴヌクレオチド合成の世界市場の予測 〜2020年:製品&サービス (プライマー・プローブ・カスタムオリゴ・試薬・機器)・エンドユーザー別

Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom Oligos, Reagent, Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global Forecast to 2020

発行 MarketsandMarkets 商品コード 311580
出版日 ページ情報 英文 230 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
オリゴヌクレオチド合成の世界市場の予測 〜2020年:製品&サービス (プライマー・プローブ・カスタムオリゴ・試薬・機器)・エンドユーザー別 Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom Oligos, Reagent, Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global Forecast to 2020
出版日: 2015年11月24日 ページ情報: 英文 230 Pages
概要

世界のオリゴヌクレオチド合成の市場は2015年から2020年にかけて10.1%のCAGRで推移し、2020年には10億7810万ドルの規模に成長すると予測されています。同市場の成長は、医薬品&バイオテクノロジー企業によるR&D支出の拡大、分子診断部門の成長による合成オリゴヌクレオチド需要の拡大、ゲノム技術の開発への政府による投資の拡大、ベンチャーキャピタル投資の拡大、合成遺伝子の需要の拡大などの要因によって推進されています。

当レポートでは、世界のオリゴヌクレオチド合成の市場について調査し、製品の種類と概要、市場成長推進因子・阻害因子および市場機会の分析、産業構造とバリューチェーン、製品の機能・エンドユーザー産業・地域/主要国別の主要動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 市場概要
  • 製品・サービス別市場
  • 用途別市場
  • エンドユーザー別市場
  • 地域概要

第5章 市場概要

  • イントロダクション
  • 市場区分
    • 製品・サービス別
    • 用途別
    • エンドユーザー別
    • 地域別
  • 市場力学
    • 成長推進因子
    • 成長阻害因子
    • 市場機会
    • 課題

第6章 産業動向

  • イントロダクション
  • ポーターのファイブフォース分析
  • サプライチェーン分析

第7章 市場分析:製品・サービス別

  • イントロダクション
  • 合成オリゴヌクレオチド
    • 製品
      • プライマー
      • プローブ
      • 大規模合成オリゴ
      • 中間規模合成オリゴヌクレオチド
    • サービス
      • カスタムオリゴヌクレオチド
      • 事前設計済みオリゴヌクレオチド
  • 試薬
  • 機器

第8章 市場分析:用途別

  • イントロダクション
  • 研究
    • PCR
    • 定量PCR(qPCR)
    • シーケンシング
    • 遺伝子合成
    • 他の研究用途
  • 診断
  • 治療
    • DNA/アンチセンスオリゴヌクレオチド
    • RNA干渉(RNAi)
    • アプタマー
    • 他の治療用途

第9章 市場分析:エンドユーザー別

  • イントロダクション
  • 学術機関
  • 診断ラボ
  • 医薬品・バイオテクノロジー企業
  • その他

第10章 地域分析

  • イントロダクション
  • PEST分析
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • その他
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第11章 競合環境

  • 概要
  • 市場シェア分析
  • 競合状況・動向
    • 新製品の投入
    • 提携・契約・合意・協力
    • 拡張
    • 買収

第12章 企業プロファイル

  • イントロダクション
  • INTEGRATED DNA TECHNOLOGIES, INC. (IDT)
  • SIGMA-ALDRICH CORPORATION
  • EUROFINS GENOMICS
  • THERMO FISHER SCIENTIFIC, INC.
  • BIOAUTOMATION CORPORATION
  • AGILENT TECHNOLOGIES, INC.
  • BIOSEARCH TECHNOLOGIES, INC.
  • EUROGENTEC S.A.
  • GENERAL ELECTRIC COMPANY (GE)
  • GEN9, INC.
  • GENEDESIGN, INC.
  • GENSCRIPT USA INC.
  • NITTO DENKO AVECIA INC. (AVECIA)
  • TRILINK BIOTECHNOLOGIES, INC.
    • 企業概要
    • 財務動向
    • 製品・サービス
    • 戦略
    • 近年の発展動向、など

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2680

The oligonucleotide synthesis market is poised to reach USD 1,918.6 million by 2020 from USD 1,078.1 million in 2015, growing at a CAGR of 10.1% from 2015 to 2020. This market is categorized on the basis of products and services, applications, end users, and regions.

Major factors contributing to the growth of the global oligonucleotide synthesis market include increasing R&D expenses in the pharmaceutical and biotechnology companies, rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, and increasing demand for synthetic genes. The increasing applications of oligonucleotides in nucleic acid array-based technologies, library preparations, next-generation sequencing (NGS), genomics, nucleic acid-base detections, cell cultures, diagnostics, therapeutics, human identity testing, cloning, genetic engineering, and synthetic biology also play a vital role in the development of this market. However, price erosion and lack of regulations for therapeutic oligonucleotides could hinder the growth of this market.

North America commands the largest share of the global oligonucleotide synthesis market in 2015 and is expected to witness the second-highest growth rate from 2015 to 2020. According to the Centers for Disease Control and Prevention (CDC), in 2014, chronic diseases accounted for 7 out of 10 deaths and 86% of healthcare costs in the U.S. It was reported that ~50% of Americans suffer from at least one chronic disease. Considering the potential of oligonucleotides (therapeutic oligonucleotides) in the treatment of chronic diseases, the oligonucleotide synthesis market is expected to flourish in the coming years, provided these drugs get rapid market approvals.

Apart from the comprehensive regional analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, and change in strategic approach; R&D investments; and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the oligonucleotide synthesis market. The report analyzes the oligonucleotide synthesis market by products and services, application, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the oligonucleotide synthesis market
  • Competitive Assessment: In-depth assessment of market strategies, market shares, regional and business segments, and product portfolios of the leading players in the oligonucleotide synthesis market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for oligonucleotide synthesis across regions
  • Market Diversification: Exhaustive information about new products and services, untapped regions, recent developments, and investments in the oligonucleotide synthesis market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. KEY INDUSTRY INSIGHTS
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. OLIGONUCLEOTIDE SYNTHESIS MARKET OVERVIEW
  • 4.2. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCTS & SERVICES
  • 4.3. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION
  • 4.4. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER
  • 4.5. GEOGRAPHIC SNAPSHOT OF THE OLIGONUCLEOTIDE SYNTHESIS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY PRODUCTS & SERVICES
    • 5.2.2. BY APPLICATION
    • 5.2.3. BY END USER
    • 5.2.4. BY REGION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Increasing R&D expenditure in pharmaceutical & biotechnology companies
      • 5.3.1.2. Growing field of molecular diagnostics
      • 5.3.1.3. Increasing government investments to develop genomic technologies
      • 5.3.1.4. Rise in venture capital investments
      • 5.3.1.5. Increasing demand for synthetic genes
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Price erosion of synthesized oligos
      • 5.3.2.2. Lack of regulations for therapeutic oligos
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Emerging Asian markets
      • 5.3.3.2. Developing field of next-generation sequencing
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Localization of business
      • 5.3.4.2. Large-scale synthesis of oligonucleotides

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
    • 6.1.1. INDUSTRY TRENDS
  • 6.2. PORTER'S FIVE FORCES ANALYSIS
    • 6.2.1. THREAT FROM NEW ENTRANTS
    • 6.2.2. THREAT FROM SUBSTITUTES
    • 6.2.3. BARGAINING POWER OF SUPPLIERS
    • 6.2.4. BARGAINING POWER OF BUYERS
    • 6.2.5. INTENSITY OF COMPETITIVE RIVALRY
  • 6.3. SUPPLY CHAIN ANALYSIS
    • 6.3.1. KEY INFLUENCERS

7. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCTS & SERVICES

  • 7.1. INTRODUCTION
  • 7.2. SYNTHESIZED OLIGONUCLEOTIDES
    • 7.2.1. SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY PRODUCT
      • 7.2.1.1. Primers
      • 7.2.1.2. Probes
      • 7.2.1.3. Large-scale synthesis oligos
      • 7.2.1.4. Intermediate-scale synthesis oligonucleotides
    • 7.2.2. SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY SERVICE
      • 7.2.2.1. Custom Oligonucleotides
      • 7.2.2.2. Pre-designed oligonucleotides
    • 7.2.3. REAGENTS
    • 7.2.4. EQUIPMENT

8. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. RESEARCH
    • 8.2.1. PCR
    • 8.2.2. QPCR
    • 8.2.3. SEQUENCING
    • 8.2.4. GENE SYNTHESIS
    • 8.2.5. OTHER RESEARCH APPLICATIONS
  • 8.3. DIAGNOSTICS
  • 8.4. THERAPEUTICS
    • 8.4.1. DNA/ANTISENSE OLIGOS
    • 8.4.2. RNAI
    • 8.4.3. NUCLEIC ACID APTAMERS
    • 8.4.4. OTHER THERAPEUTIC APPLICATIONS

9. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. ACADEMIC RESEARCH INSTITUTES
  • 9.3. DIAGNOSTIC LABORATORIES
  • 9.4. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 9.5. OTHER END USERS

10. REGIONAL ANALYSIS

  • 10.1. INTRODUCTION
  • 10.2. PEST ANALYSIS
    • 10.2.1. POLITICAL FACTORS
    • 10.2.2. ECONOMIC FACTORS
    • 10.2.3. SOCIAL FACTORS
    • 10.2.4. TECHNOLOGICAL FACTORS
  • 10.3. NORTH AMERICA
    • 10.3.1. U.S.
    • 10.3.2. CANADA
  • 10.4. EUROPE
    • 10.4.1. GERMANY
    • 10.4.2. FRANCE
    • 10.4.3. U.K.
    • 10.4.4. REST OF EUROPE (ROE)
  • 10.5. ASIA-PACIFIC (APAC)
  • 10.6. LATIN AMERICA (LATAM)
  • 10.7. MIDDLE EAST AND AFRICA (MEA)

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. NEW PRODUCT LAUNCHES
    • 11.3.2. PARTNERSHIPS, AGREEMENTS, CONTRACTS, AND COLLABORATIONS
    • 11.3.3. EXPANSIONS
    • 11.3.4. ACQUISITIONS

12. COMPANY PROFILE

  • 12.1. INTRODUCTION
  • 12.2. INTEGRATED DNA TECHNOLOGIES, INC. (IDT)
  • 12.3. SIGMA-ALDRICH CORPORATION
  • 12.4. EUROFINS GENOMICS
  • 12.5. THERMO FISHER SCIENTIFIC, INC.
  • 12.6. BIOAUTOMATION CORPORATION
  • 12.7. AGILENT TECHNOLOGIES, INC.
  • 12.8. BIOSEARCH TECHNOLOGIES, INC.
  • 12.9. EUROGENTEC S.A.
  • 12.10. GENERAL ELECTRIC COMPANY (GE)
  • 12.11. GEN9, INC.
  • 12.12. GENEDESIGN, INC.
  • 12.13. GENSCRIPT USA INC.
  • 12.14. NITTO DENKO AVECIA INC. (AVECIA)
  • 12.15. TRILINK BIOTECHNOLOGIES, INC.

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

13. APPENDIX

  • 13.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. OTHER DEVELOPMENTS, BY COMPANY, 2012-2015
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: INCREASING R&D EXPENDITURE IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IS PROPELLING THE GROWTH OF OLIGONUCLEOTIDE SYNTHESIS MARKET
  • TABLE 2: PRICE EROSION OF SYNTHESIZED OLIGOS RESTRAINTS THE GROWTH OF OLIGONUCLEOTIDE SYNTHESIS MARKET
  • TABLE 3: EMERGING ASIA-PACIFIC MARKETS ARE PAVING NEW GROWTH AVENUES FOR PLAYERS IN OLIGONUCLEOTIDE SYNTHESIS MARKET
  • TABLE 4: LOCALIZATION OF BUSINESS CAN BE A MAJOR CHALLENGE FOR THE GROWTH OF OLIGONUCLEOTIDE SYNTHESIS MARKET
  • TABLE 5: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 6: NORTH AMERICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 7: EUROPE: SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 8: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 9: GLOBAL PRIMERS MARKET, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: NORTH AMERICA: PRIMERS MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 11: EUROPE: PRIMERS MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 12: GLOBAL PROBES MARKET, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: NORTH AMERICA: PROBES MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 14: EUROPE: PROBES MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 15: GLOBAL LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: NORTH AMERICA: LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 17: EUROPE: LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 18: GLOBAL INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: NORTH AMERICA: INTERMEDIATE SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 20: EUROPE: INTERMEDIATE SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 21: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 22: GLOBAL CUSTOM OLIGONUCLEOTIDES MARKET, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: NORTH AMERICA: CUSTOM OLIGONUCLEOTIDES MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 24: EUROPE: CUSTOM OLIGONUCLEOTIDES MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 25: GLOBAL PRE-DESIGNED OLIGONUCLEOTIDES MARKET, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 26: NORTH AMERICA: PRE-DESIGNED OLIGONUCLEOTIDES MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 27: EUROPE: PRE-DESIGNED OLIGONUCLEOTIDES MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 28: GLOBAL OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 30: EUROPE: OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 31: GLOBAL OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 32: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 33: EUROPE: OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 34: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 35: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 36: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 37: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 38: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 39: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PCR APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 40: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PCR APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 41: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PCR APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 42: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR QPCR APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 43: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR QPCR APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 44: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR QPCR APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 45: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR SEQUENCING APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 46: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR SEQUENCING APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 47: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR SEQUENCING APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 48: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR GENE SYNTHESIS APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 49: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR GENE SYNTHESIS APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 50: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR GENE SYNTHESIS APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 51: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 52: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 53: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 54: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 55: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 56: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 57: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 58: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 59: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 60: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 61: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DNA/ANTISENSE OLIGOS APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 62: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DNA/ANTISENSE OLIGOS APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 63: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DNA/ANTISENSE OLIGOS APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 64: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RNAI APPLICATIONS, BY REGION, 2013-2020 (USD MILLION
  • TABLE 65: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RNAI APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 66: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RNAI APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 67: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR NUCLEIC ACID APTAMER APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 68: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR NUCLEIC ACID APTAMER APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 69: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR NUCLEIC ACID APTAMER APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 70: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2013-2020 (USD THOUSAND)
  • TABLE 71: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD THOUSAND)
  • TABLE 72: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD THOUSAND)
  • TABLE 73: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 74: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 75: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 76: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 77: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 78: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 79: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 80: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 81: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 82: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 83: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 84: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 85: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 86: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 87: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 88: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 89: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 90: NORTH AMERICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 91: NORTH AMERICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 92: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 93: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 94: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 95: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 96: U.S.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 97: U.S.: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 98: U.S.: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 99: U.S.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 100: U.S.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 101: U.S.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 102: U.S.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 103: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 104: CANADA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 105: CANADA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 106: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 107: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 108: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 109: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 110: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 111: EUROPE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 112: EUROPE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 113: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 114: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 115: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 116: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 117: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 118: GERMANY: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 119: GERMANY: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 120: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 121: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 122: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 123: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 124: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 125: FRANCE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 126: FRANCE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 127: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 128: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 129: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 130: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 131: U.K.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 132: U.K.: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 133: U.K.: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 134: U.K.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 135: U.K.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 136: U.K.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 137: U.K.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 138: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 139: ROE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 140: ROE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 141: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 142: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 143: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 144: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 145: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 146: ASIA-PACIFIC: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 147: ASIA-PACIFIC: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 148: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 149: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 150: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 151: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 152: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 153: LATIN AMERICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 154: LATIN AMERICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 155: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 156: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 157: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 158: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 159: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
  • TABLE 160: MIDDLE EAST & AFRICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 161: MIDDLE EAST & AFRICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
  • TABLE 162: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 163: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 164: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 165: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 166: NEW PRODUCT LAUNCHES (2012-2015)
  • TABLE 167: PARTNERSHIPS, AGREEMENTS, CONTRACTS, AND COLLABORATIONS (2012-2015)
  • TABLE 168: EXPANSIONS (2012-2015)
  • TABLE 169: ACQUISITIONS (2012-2015)
  • TABLE 170: AGILENT TECHNOLOGIES, INC.
  • TABLE 171: BIOAUTOMATION CORPORATION
  • TABLE 172: BIOSEARCH TECHNOLOGIES
  • TABLE 173: EUROFINS GENOMICS
  • TABLE 174: EUROGENTEC S.A.
  • TABLE 175: GENERAL ELECTRIC COMPANY (GE)
  • TABLE 176: GEN9, INC.
  • TABLE 177: GENDESIGN, INC.
  • TABLE 178: GENSCRIPT USA, INC.
  • TABLE 179: INTEGRATED DNA TECHNOLOGIES, INC. (IDT)
  • TABLE 180: NITTO DENKO AVECIA, INC. (AVECIA)
  • TABLE 181: SIGMA-ALDRICH CORPORATION
  • TABLE 182: THERMO FISHER SCIENTIFIC, INC.
  • TABLE 183: TRILINK BIOTECHNOLOGIES, INC.

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 7: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 8: SYNTHESIZED OLIGONUCLEOTIDES SEGMENT TO DOMINATE THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 9: INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES SEGMENT TO GROW AT THE HIGHEST RATE (2015-2020)
  • FIGURE 10: CUSTOM OLIGOS SEGMENT TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES
  • FIGURE 11: RESEARCH SEGMENT TO DOMINATE THE OLIGONUCLEOTIDE SYNTHESIS APPLICATIONS MARKET (2015)
  • FIGURE 12: DIAGNOSTIC LABORATORIES END-USER SEGMENT TO GROW AT THE HIGHEST CAGR (2015-2020)
  • FIGURE 13: NORTH AMERICA EXPECTED TO HOLD THE LARGEST SHARE IN 2015, ASIA-PACIFIC TO WITNESS HIGHEST GROWTH (2015-2020)
  • FIGURE 14: SYNTHESIZED OLIGONUCLEOTIDES SEGMENT TO OFFER HIGH GROWTH OPPORTUNITIES FOR THE OLIGONUCLEOTIDE SYNTHESIS MARKET
  • FIGURE 15: PRIMERS EXPECTED TO BE THE MAJOR CONTRIBUTING SEGMENT BETWEEN 2015 TO 2020
  • FIGURE 16: CUSTOM OLIGOS TO DOMINATE THE SYNTHESIZED OLIGONUCLEOTIDES SERVICES SEGMENT FROM 2015 TO 2020
  • FIGURE 17: PCR TO COMMAND THE LARGEST SHARE OF THE RESEARCH APPLICATIONS MARKET IN 2015
  • FIGURE 18: RNAI SEGMENT EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 19: DIAGNOSTIC LABORATORIES SEGMENT TO WITNESS HIGHEST GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 20: ASIA-PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 21: OLIGONUCLEOTIDE SYNTHESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22: PRICE EROSION AFFECTING INDUSTRY GROWTH
  • FIGURE 23: SYNTHESIZED OLIGONUCLEOTIDES TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 24: ASIA-PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 25: INTERMEDIATE SCALE SYNTHESIS SEGMENT TO GROW AT THE HIGHEST RATE
  • FIGURE 26: CUSTOM OLIGONUCLEOTIDES DOMINATES THE OLIGONUCLEOTIDE SYNTHESIS MARKET BY SERVICES IN 2015
  • FIGURE 27: NORTH AMERICA TO DOMINATE THE REAGENTS MARKET IN 2015
  • FIGURE 28: ASIA-PACIFIC TO GROW AT A HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 29: THE DIAGNOSTIC APPLICATIONS SEGMENT OFFERS LUCRATIVE GROWTH OPPORTUNITIES FOR MARKET PLAYERS DURING THE FORECAST PERIOD
  • FIGURE 30: THE PCR SEGMENT TO DOMINATE THE RESEARCH APPLICATIONS MARKET IN 2015
  • FIGURE 31: ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 32: THE RNAI SEGMENT TO DOMINATE THE THERAPEUTIC APPLICATIONS MARKET IN 2015
  • FIGURE 33: DIAGNOSTIC LABORATORIES TO OFFER LUCRATIVE GROWTH OPPORTUNITIES
  • FIGURE 34: ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 35: ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 36: NORTH AMERICA TO DOMINATE THE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES SEGMENT IN 2015
  • FIGURE 37: NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 38: EUROPEAN OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 39: ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET
  • FIGURE 40: LATIN AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 41: MIDDLE EAST AND AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 42: KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2012 AND 2015
  • FIGURE 43: MARKET EVOLUTION FRAMEWORK
  • FIGURE 44: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 45: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS
  • FIGURE 46: OLIGONUCLEOTIDE SYNTHESIS BENCHMARKING FOR TOP 5 PLAYERS
  • FIGURE 47: SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT
  • FIGURE 48: EUROFINS SCIENTIFIC GROUP: COMPANY SNAPSHOT
  • FIGURE 49: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 50: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 51: KANEKA CORPORATION: COMPANY SNAPSHOT
  • FIGURE 52: GENERAL ELECTRIC COMPANY (GE): COMPANY SNAPSHOT
  • FIGURE 53: NITTO DENKO GROUP: COMPANY SNAPSHOT
Back to Top